{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:34:40Z","timestamp":1779122080174,"version":"3.51.4"},"reference-count":61,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Provost Research Incentive Fund","award":["17GRNT33460327"],"award-info":[{"award-number":["17GRNT33460327"]}]},{"name":"ASU Skysong Innovations Award","award":["17GRNT33460327"],"award-info":[{"award-number":["17GRNT33460327"]}]},{"name":"startup funding from the Biodesign Institute","award":["17GRNT33460327"],"award-info":[{"award-number":["17GRNT33460327"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Duchenne muscular dystrophy is an X-linked disease afflicting 1 in 3500 males that is characterized by muscle weakness and wasting during early childhood, and loss of ambulation and death by early adulthood. Chronic inflammation due to myofiber instability leads to fibrosis, which is a primary cause of loss of ambulation and cardiorespiratory insufficiency. Current standard of care focuses on reducing inflammation with corticosteroids, which have serious adverse effects. It is imperative to identify alternate immunosuppressants as treatments to reduce fibrosis and mortality. Serp-1, a Myxoma virus-derived 55 kDa secreted glycoprotein, has proven efficacy in a range of animal models of acute inflammation, and its safety and efficacy has been shown in a clinical trial. In this initial study, we examined whether pegylated Serp-1 (PEGSerp-1) treatment would ameliorate chronic inflammation in a mouse model for Duchenne muscular dystrophy. Our data revealed a significant reduction in diaphragm fibrosis and increased myofiber diameter, and significantly decreased pro-inflammatory M1 macrophage infiltration. The M2a macrophage and overall T cell populations showed no change. These data demonstrate that treatment with this new class of poxvirus-derived immune-modulating serpin has potential as a therapeutic approach designed to ameliorate DMD pathology and facilitate muscle regeneration.<\/jats:p>","DOI":"10.3390\/biomedicines10051154","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T08:34:29Z","timestamp":1652776469000},"page":"1154","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Myxomavirus Serp-1 Protein Ameliorates Inflammation in a Mouse Model of Duchenne Muscular Dystrophy"],"prefix":"10.3390","volume":"10","author":[{"given":"Alexander B.","family":"Andre","sequence":"first","affiliation":[{"name":"Molecular and Cellular Biology Graduate Program, School of Life Sciences, Arizona State University, Tempe, AZ 85287, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8808-8996","authenticated-orcid":false,"given":"Liqiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Biodesign Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA"},{"name":"Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jalen D.","family":"Nix","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Biology Graduate Program, School of Life Sciences, Arizona State University, Tempe, AZ 85287, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Elmadbouly","sequence":"additional","affiliation":[{"name":"Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra R.","family":"Lucas","sequence":"additional","affiliation":[{"name":"Biodesign Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA"},{"name":"Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3704-6956","authenticated-orcid":false,"given":"Jeanne","family":"Wilson-Rawls","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Biology Graduate Program, School of Life Sciences, Arizona State University, Tempe, AZ 85287, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Rawls","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Biology Graduate Program, School of Life Sciences, Arizona State University, Tempe, AZ 85287, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","article-title":"A Systematic Review and Meta-Analysis on the Epidemiology of Duchenne and Becker Muscular Dystrophy","volume":"24","author":"Mah","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.yjmcc.2012.12.009","article-title":"Cardiac Phenotype of Duchenne Muscular Dystrophy: Insights from Cellular Studies","volume":"58","author":"Shirokova","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Mavrogeni, S., Papavasiliou, A., Spargias, K., Constandoulakis, P., Papadopoulos, G., Karanasios, E., Georgakopoulos, D., Kolovou, G., Demerouti, E., and Polymeros, S. (2010). Myocardial Inflammation in Duchenne Muscular Dystrophy as a Precipitating Factor for Heart Failure: A Prospective Study. BMC Neurol., 10.","DOI":"10.1186\/1471-2377-10-33"},{"key":"ref_4","first-page":"184","article-title":"The Role of Fibrosis in Duchenne Muscular Dystrophy","volume":"31","author":"Klingler","year":"2012","journal-title":"Acta Myol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00028.2001","article-title":"Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle","volume":"82","author":"Blake","year":"2002","journal-title":"Physiol. Rev."},{"key":"ref_6","first-page":"345","article-title":"Targeted Inactivation of Myogenic Factor Genes Reveals Their Role during Mouse Myogenesis: A Review","volume":"40","author":"Arnold","year":"2003","journal-title":"Int. J. Dev. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"R1173","DOI":"10.1152\/ajpregu.00735.2009","article-title":"Regulatory Interactions between Muscle and the Immune System during Muscle Regeneration","volume":"298","author":"Tidball","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1177\/002215540104900807","article-title":"The Role of Tumor Necrosis Factor-Alpha (TNF-\u03b1) in Skeletal Muscle Regeneration: Studies in TNF-\u03b1(-\/-) and TNF-\u03b1(-\/-)\/LT-\u03b1(-\/-) Mice","volume":"49","author":"Collins","year":"2001","journal-title":"J. Histochem. Cytochem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"C1183","DOI":"10.1152\/ajpcell.00568.2007","article-title":"Endogenous Interferon-\u03b3 Is Required for Efficient Skeletal Muscle Regeneration","volume":"294","author":"Cheng","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1084\/jem.20070075","article-title":"Inflammatory Monocytes Recruited after Skeletal Muscle Injury Switch into Antiinflammatory Macrophages to Support Myogenesis","volume":"204","author":"Arnold","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/hmg\/ddq523","article-title":"Interleukin-10 Reduces the Pathology of Mdx Muscular Dystrophy by Deactivating M1 Macrophages and Modulating Macrophage Phenotype","volume":"20","author":"Villalta","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1083\/jcb.150.5.1209","article-title":"The Dystrophin Complex Forms a Mechanically Strong Link between the Sarcolemma and Costameric Actin","volume":"150","author":"Rybakova","year":"2000","journal-title":"J. Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1016\/j.yexcr.2010.05.035","article-title":"Regulation and Dysregulation of Fibrosis in Skeletal Muscle","volume":"316","author":"Serrano","year":"2010","journal-title":"Exp. Cell Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1111\/febs.12166","article-title":"Monocyte\/Macrophage Interactions with Myogenic Precursor Cells during Skeletal Muscle Regeneration","volume":"280","author":"Saclier","year":"2013","journal-title":"FEBS J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e4761427","DOI":"10.1155\/2019\/4761427","article-title":"Macrophages Are Key Regulators of Stem Cells during Skeletal Muscle Regeneration and Diseases","volume":"2019","author":"Dort","year":"2019","journal-title":"Stem Cells Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3389\/fimmu.2015.00602","article-title":"Macrophages During the Fibrotic Process:M2 as friend and Foe","volume":"6","author":"Braga","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.addr.2018.02.009","article-title":"Tackling Muscle Fibrosis: From Molecular Mechanisms to next Generation Engineered Models to Predict Drug Delivery","volume":"129","author":"Bersini","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm.3869","article-title":"Nilotinib Reduces Muscle Fibrosis in Chronic Muscle Injury by Promoting TNF-Mediated Apoptosis of Fibro\/Adipogenic Progenitors","volume":"21","author":"Lemos","year":"2015","journal-title":"Nat. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1182\/blood.V99.8.2835","article-title":"Plasmin Activity Is Required for Myogenesis in vitro and Skeletal Muscle Regeneration in vivo","volume":"99","author":"Suelves","year":"2002","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.2741\/1754","article-title":"The Plasminogen Activation System in Skeletal Muscle Regeneration: Antagonistic Roles of Urokinase-Type Plasminogen Activator (Upa) and Its Inhibitor (PAI-1)","volume":"10","author":"Suelves","year":"2005","journal-title":"Front. Biosci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1083\/jcb.200705127","article-title":"UPA Deficiency Exacerbates Muscular Dystrophy in MDX Mice","volume":"178","author":"Suelves","year":"2007","journal-title":"J. Cell Biol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Rahman, F.A., Angus, S.A., Stokes, K., Karpowicz, P., and Krause, M.P. (2020). Impaired ECM Remodeling and Macrophage Activity Define Necrosis and Regeneration Following Damage in Aged Skeletal Muscle. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134575"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1073\/pnas.80.10.2956","article-title":"Detection of an Unusually Stable Fibrinolytic Inhibitor Produced by Bovine Endothelial Cells","volume":"80","author":"Loskutoff","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1172\/JCI112761","article-title":"CDNA Cloning of Human Plasminogen Activator-Inhibitor from Endothelial Cells","volume":"78","author":"Ginsburg","year":"1986","journal-title":"J. Clin. Invest."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1093\/emboj\/16.10.2610","article-title":"Recycling of the Urokinase Receptor upon Internalization of the UPA:Serpin Complexes","volume":"16","author":"Nykjaer","year":"1997","journal-title":"EMBO J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/sj.onc.1204261","article-title":"Urokinase\/Urokinase Receptor and Vitronectin\/Av\u03b23 Integrin Induce Chemotaxis and Cytoskeleton Reorganization through Different Signaling Pathways","volume":"20","author":"Degryse","year":"2001","journal-title":"Oncogene"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1083\/jcb.201105013","article-title":"PAI-1\u2013Regulated MiR-21 Defines a Novel Age-Associated Fibrogenic Pathway in Muscular Dystrophy","volume":"196","author":"Ardite","year":"2012","journal-title":"J. Cell Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"C217","DOI":"10.1152\/ajpcell.00555.2004","article-title":"Mice Deficient in Plasminogen Activator Inhibitor-1 Have Improved Skeletal Muscle Regeneration","volume":"289","author":"Koh","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood.V97.6.1703","article-title":"Urokinase-Dependent Plasminogen Activation Is Required for Efficient Skeletal Muscle Regeneration in Vivo","volume":"97","author":"Roma","year":"2001","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.0000000000002337","article-title":"Practice Guideline Update Summary: Corticosteroid Treatment of Duchenne Muscular Dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","author":"Gloss","year":"2016","journal-title":"Neurology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13023-021-01758-9","article-title":"Standard of Care versus New-Wave Corticosteroids in the Treatment of Duchenne Muscular Dystrophy: Can We Do Better?","volume":"16","author":"Kourakis","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1183\/09031936.95.08050824","article-title":"Rat Diaphragm Contractility and Histopathology Are Affected Differently by Low Dose Treatment with Methylprednisolone and Deflazacort","volume":"8","author":"Dekhuijzen","year":"1995","journal-title":"Eur. Respir. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4103\/2230-8210.117215","article-title":"Glucocorticoid-Induced Myopathy: Pathophysiology, Diagnosis, and Treatment","volume":"17","author":"Gupta","year":"2013","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Fappi, A., de Neves, J.C., Sanches, L.N., Massaroto e Silva, P.V., Sikusawa, G.Y., Brand\u00e3o, T.P.C., Chadi, G., and Zanoteli, E. (2019). Skeletal Muscle Response to Deflazacort, Dexamethasone and Methylprednisolone. Cells, 8.","DOI":"10.3390\/cells8050406"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.nmd.2008.03.002","article-title":"Corticosteroid Treatment Retards Development of Ventricular Dysfunction in Duchenne Muscular Dystrophy","volume":"18","author":"Markham","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pediatrneurol.2007.11.001","article-title":"Deflazacort Use in Duchenne Muscular Dystrophy: An 8-Year Follow-Up","volume":"38","author":"Houde","year":"2008","journal-title":"Pediatr. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jpeds.2013.05.060","article-title":"Oral Corticosteroids and Onset of Cardiomyopathy in Duchenne Muscular Dystrophy","volume":"163","author":"Barber","year":"2013","journal-title":"J. Pediatr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.nmd.2017.05.019","article-title":"Associations between Timing of Corticosteroid Treatment Initiation and Clinical Outcomes in Duchenne Muscular Dystrophy","volume":"27","author":"Kim","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"18563","DOI":"10.1074\/jbc.M209683200","article-title":"Serp-1, a Viral Anti-Inflammatory Serpin, Regulates Cellular Serine Proteinase and Serpin Responses to Vascular Injury","volume":"278","author":"Dai","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/01.RES.0000090993.01633.D4","article-title":"Serine Protease Inhibitor Serp-1 Strongly Impairs Atherosclerotic Lesion Formation and Induces a Stable Plaque Phenotype in ApoE\u2212\/\u2212 Mice","volume":"93","author":"Bot","year":"2003","journal-title":"Circ. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/01.tp.0000203141.02725.8a","article-title":"Prevention of Chronic Renal Allograft Rejection by SERP-1 Protein","volume":"81","author":"Jiang","year":"2006","journal-title":"Transplantation"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Kwiecien, J.M., Dabrowski, W., Kwiecien-Delaney, B.J., Kwiecien-Delaney, C.J., Siwicka-Gieroba, D., Yaron, J.R., Zhang, L., Delaney, K.H., and Lucas, A.R. (2020). Neuroprotective Effect of Subdural Infusion of Serp-1 in Spinal Cord Trauma. Biomedicines, 8.","DOI":"10.3390\/biomedicines8100372"},{"key":"ref_43","first-page":"70","article-title":"PEGylated Serp-1 Markedly Reduces Pristane-Induced Experimental Diffuse Alveolar Hemorrhage, Altering UPAR Distribution, and Macrophage Invasion","volume":"8","author":"Guo","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"108764","DOI":"10.1016\/j.clim.2021.108764","article-title":"Myxomavirus Serpin Alters Macrophage Function and Prevents Diffuse Alveolar Hemorrhage in Pristane-Induced Lupus","volume":"229","author":"Zhuang","year":"2021","journal-title":"Clin. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3389\/fcvm.2021.649124","article-title":"Serp-1 Promotes Corneal Wound Healing by Facilitating Re-Epithelialization and Inhibiting Fibrosis and Angiogenesis","volume":"8","author":"Ju","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0092-8674(00)80533-4","article-title":"Skeletal and Cardiac Myopathies in Mice Lacking Utrophin and Dystrophin: A Model for Duchenne Muscular Dystrophy","volume":"90","author":"Grady","year":"1997","journal-title":"Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","article-title":"Utrophin-Dystrophin-Deficient Mice as a Model for Duchenne Muscular Dystrophy","volume":"90","author":"Deconinck","year":"1997","journal-title":"Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1002\/j.1460-2075.1988.tb03165.x","article-title":"Localization of the Mdx Mutation within the Mouse Dystrophin Gene","volume":"7","author":"Sicinski","year":"1988","journal-title":"EMBO J."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Travascio, F. (2016). The extracellular matrix complexome from skeletal muscle. Composition and Function of the Extracellular Matrix in the Human Body, InTechOpen.","DOI":"10.5772\/61601"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12974-015-0463-9","article-title":"Cyclic AMP Is a Key Regulator of M1 to M2a Phenotypic Conversion of Microglia in the Presence of Th2 Cytokines","volume":"13","author":"Ghosh","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/clim.2000.4966","article-title":"Helper (CD4(+)) and Cytotoxic (CD8(+)) T Cells Promote the Pathology of Dystrophin-Deficient Muscle","volume":"98","author":"Spencer","year":"2001","journal-title":"Clin. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Zhang, L., Yaron, J.R., Tafoya, A.M., Wallace, S.E., Kilbourne, J., Haydel, S., Rege, K., McFadden, G., and Lucas, A.R. (2019). A Virus-Derived Immune Modulating Serpin Accelerates Wound Closure with Improved Collagen Remodeling. J. Clin. Med., 8.","DOI":"10.3390\/jcm8101626"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/CIRCINTERVENTIONS.110.953885","article-title":"A Randomized Controlled, Phase 2 Trial of the Viral Serpin Serp-1 in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention","volume":"3","author":"Tardif","year":"2010","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_54","first-page":"15","article-title":"Gentamicin Administration in Duchenne Patients with Premature Stop Codon. Preliminary Results","volume":"22","author":"Politano","year":"2003","journal-title":"Acta Myol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S2213-2600(14)70100-6","article-title":"A Randomized Placebo-Controlled Trial of Ataluren for the Treatment of Nonsense Mutation Cystic Fibrosis","volume":"2","author":"Kerem","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3389\/fgene.2020.00731","article-title":"Innovative Therapeutic and Delivery Approaches Using Nanotechnology to Correct Splicing Defects Underlying Disease","volume":"11","author":"Limeres","year":"2020","journal-title":"Front. Genet."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"8041","DOI":"10.1074\/jbc.M509454200","article-title":"Identification of Myxomaviral Serpin Reactive Site Loop Sequences That Regulate Innate Immune Responses","volume":"281","author":"Dai","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1160\/TH05-07-0492","article-title":"Myxoma Viral Serpin, Serp-1, a Unique Interceptor of Coagulation and Innate Immune Pathways","volume":"95","author":"Viswanathan","year":"2006","journal-title":"Thromb. Haemost."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1096-8628(20000410)91:4<305::AID-AJMG12>3.0.CO;2-S","article-title":"Splicing Mutation in Dysferlin Produces Limb-Girdle Muscular Dystrophy with Inflammation","volume":"91","author":"McNally","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejpn.2007.02.018","article-title":"Inflammation and Response to Steroid Treatment in Limb-Girdle Muscular Dystrophy 2I","volume":"11","author":"Darin","year":"2007","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.bbrc.2007.09.066","article-title":"POMT2 Gene Mutation in Limb-Girdle Muscular Dystrophy with Inflammatory Changes","volume":"363","author":"Biancheri","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/5\/1154\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:13:35Z","timestamp":1760138015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/5\/1154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,17]]},"references-count":61,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["biomedicines10051154"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10051154","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,17]]}}}